Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
U.S. Issues Cuba Health Alert as Illnesses Rise 
3 clinical-grade skincare creams you really shouldn’t buy online 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise 
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Add as a preferred source on Google
While there is no definitive cure for cancer just yet, scientists continue to research and experiment with various methods of treatment. Recently it was reported that a new drug may help beat the disease, specifically leukemia.
Express reports that a new drug may help patients suffering from leukemia while sparing them from the toxic side-effects that may come along with the treatment. The drug is referred to as asciminib and a study that was conducted as a trial for this drug found that the patients who took it responded well and that the drug did not cause any harmful side effects. The normal drugs that help treat leukemia usually come with many unpleasant side effects like diarrhea, vomiting, and muscle pain, contributing to the pain the patients are already feeling. The researchers behind the drug say that this serves as a breakthrough as asciminib does not kill the healthy cells nor cause the side effects.
In the study with 150 participants, no one found the drug toxic in any way.
Asciminib slows down the cancer by inhibiting certain cancer-causing enzymes called Kinases, which is part of a type of drugs referred to as tyrosine kinase inhibitors or TKI. South Australian Health and Medical Research Institute Professor Tim Hughes, who also serves as a co-author of the study, believes that if asciminib is successful in its development stages, then this would be a breakthrough in treating leukemia, specifically chronic myeloid leukemia, since the 1990s.
Other breakthroughs with other types of cancer have also been made. Express previously reported that the International Alliance for Cancer Early Detection - made up of scientists from various cancer institutes in the United Kingdom - were able to create a tumor that could help them understand how a cancer is being born and so they can formulate a way to prevent the disease from evolving further.
Using cells from a person with a high risk of developing cancer, scientists hope to create a “living laboratory” to see what kind of conditions will the tumor develop. The scientists will reproduce the tissue with a 3D printer, and conduct further experiments to see what factors will be cancerous.
